Degenerative Disorder of the Temporomandibular Joint Treated With Autologous Bone Marrow-Derived Stem Cells Using the Regentime Technique: A Case Report.
| Autor: | Boulos RT; Stem Cell Transplantation/Neurology, ACE Cells Lab UK Ltd., Sheffield Rotherham, GBR., Najjoum CF; Stem Cell Transplantation/Infectious Diseases/Immunology, ACE Cells Lab UK Ltd., Sheffield Rotherham, GBR., El Asmar EA; Stem Cell Transplantation/Functional Genomics/Proteomics, ACE Cells Lab UK Ltd., Sheffield Rotherham, GBR., Abi Chahine NH; Stem Cell Transplantation/Neurological Surgery, ACE Cells Lab UK Ltd., Sheffield Rotherham, GBR. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Jan 23; Vol. 15 (1), pp. e34092. Date of Electronic Publication: 2023 Jan 23 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.34092 |
| Abstrakt: | Temporomandibular joint (TMJ) disease is a type of degenerative musculoskeletal disorder that leads to morphological and functional abnormalities. It has a poorly understood progression with numerous independent and interrelated factors, which makes it difficult for the available treatment options to meet long-term demands. We present the case of a 37-year-old woman who suffered from excruciating pain in the right temporomandibular joint, associated with limited mandibular movement. She was found to have imaging features of TMJ disorder. She underwent the Regentime procedure which uses autologous bone marrow-derived stem cells that are partially differentiated and redirected to the targeted tissue. Clinical follow-up showed total clinical recovery. Competing Interests: Intellectual Property Office Priority Document Access Service (PDAS) Reference: Regentime Brain Patent application number: GB1712971.9 Full name of the first applicant: Abi Chahin, Dr. Nassim Date 13 August 2017 (Copyright © 2023, Boulos et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|